- Home
- EVRG vs ASND Comparison
EVRG vs ASND Comparison
Compare EVRG & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVRG | ASND |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.3B | 14.7B |
| IPO Year | 2017 | 2014 |
Fundamental Metrics
Financial Performance| Metric | EVRG | ASND |
|---|---|---|
| Price | $82.74 | $222.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 16 |
| Target Price | $87.38 | ★ $281.50 |
| AVG Volume (30 Days) | ★ 1.4M | 751.0K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.42% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.66 | N/A |
| Revenue | ★ $5,961,600,000.00 | N/A |
| Revenue This Year | $6.52 | $96.35 |
| Revenue Next Year | $7.12 | $44.91 |
| P/E Ratio | $22.66 | ★ N/A |
| Revenue Growth | ★ 1.95 | N/A |
| 52 Week Low | $64.75 | $151.11 |
| 52 Week High | $85.27 | $250.74 |
Technical Indicators
Market Signals| Indicator | EVRG | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 55.02 | 43.01 |
| Support Level | $75.04 | $214.92 |
| Resistance Level | $83.53 | $233.88 |
| Average True Range (ATR) | 1.34 | 7.56 |
| MACD | 0.06 | -2.06 |
| Stochastic Oscillator | 72.34 | 16.98 |
Price Performance
Historical ComparisonAbout EVRG Evergy Inc.
Evergy is a regulated electric utility serving eastern Kansas and western Missouri. Major operating subsidiaries include Evergy Metro, Evergy Kansas Central, Evergy Missouri West, and Evergy Transmission. The utility has a combined rate base of more than $20 billion, about half in Kansas and the rest split between Missouri and interstate transmission. Evergy is one of the largest wind energy suppliers in the US.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.